Thymic Hyperplasia
What's New
Last Posted: Mar 03, 2023
- Refractory myasthenia gravis: Characteristics of a portuguese cohort.
Santos Ernestina, et al. Muscle & nerve 2019 0 (2) 188-191 - Polymorphic mutations in the polb gene promoter and their impact on transcriptional activity.
Wu Qingjun, et al. Thoracic cancer 2022 0 (6) 853-857 - Two polymorphic mutations in promoter region of DNA polymerase ? in relatively higher percentage of thymic hyperplasia patients.
Wu Qingjun, et al. Thoracic cancer 2020 12 - The thymidylate synthase enhancer region (TSER) polymorphism increases the risk of thymic lymphoid hyperplasia in patients with Myasthenia Gravis.
Lopomo Angela, et al. Gene 2017 11 - Human Leucocyte Antigen B50 Is Associated with Conversion to Generalized Myasthenia Gravis in Patients with Pure Ocular Onset.
Tiftikcioglu Bedile Irem, et al. Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2017 0 (1) 71-77 - Investigating Factors Associated with Thymic Regeneration after Chemotherapy in Patients with Lymphoma.
Sun Dao-Ping, et al. Frontiers in immunology 2016 0 654 - Elevated plasma interleukin-17A in a subgroup of Myasthenia Gravis patients.
Xie Yanchen, et al. Cytokine 2015 11 44-46 - [Study of the association of ß2-adrenergic receptor gene polymorphism with Myasthenia Gravis associated with thymus abnormality].
Wang Lili, et al. Zhonghua yi xue za zhi 2015 5 (19) 1518-21 - Clinical characteristics and therapeutic evaluation of childhood myasthenia gravis.
Yang Zhi-Xiao, et al. Experimental and therapeutic medicine 2015 4 (4) 1363-1368 - Thymic hyperplasia
From NCATS Genetic and Rare Diseases Information Center
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 25, 2024
- Content source: